Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 335,574 |
|
|||||
| News | (1) | ||||||
| Day High | 8.34 | Low High |
|||||
| Day Low | 7.98 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CareDx Inc | CDNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.25 | 3.10% | 8.32 | 15:57:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.01 | 7.98 | 8.34 | 8.07 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,285 | 335,574 | $ 8.14 | $ 2,731,873 | - | 4.80 - 12.93 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:57:36 | 100 | $ 8.32 | USD |
CareDx Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 424.58M | 51.78M | - | 280.32M | -190.28M | -3.68 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CareDx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.01 | 9.14 | 7.84 | 8.23 | 900,181 | -0.69 | -7.66% |
| 1 Month | 9.83 | 11.10 | 7.84 | 9.25 | 628,065 | -1.51 | -15.36% |
| 3 Months | 11.05 | 12.8337 | 7.83 | 9.71 | 897,600 | -2.73 | -24.71% |
| 6 Months | 5.63 | 12.93 | 4.80 | 9.31 | 1,064,551 | 2.69 | 47.78% |
| 1 Year | 8.93 | 12.93 | 4.80 | 9.02 | 941,128 | -0.61 | -6.83% |
| 3 Years | 73.38 | 96.88 | 4.80 | 23.70 | 897,332 | -65.06 | -88.66% |
| 5 Years | 26.51 | 99.83 | 4.80 | 28.86 | 827,284 | -18.19 | -68.62% |
CareDx Description
| CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden. |
